Research published in Nature Genetics on Oct.14, by Yale Cancer Center researchers at Yale School of Medicine, found a higher concentration of a specific kind of DNA—extrachromosomal or ecDNA—in more aggressive and advanced cancers that could mark them as targets for future therapies.
Medical Xpress – latest medical and health news stories
